LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 27.84 | 770.25 | 1783 | 2833 | 0.6292 | 0.5630 | MN20160304_L02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 30.06 | 770.25 | 2230 | 3106 | 0.7179 | 0.6963 | MN20160304_L02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 30.06 | 770.25 | 1860 | 3106 | 0.5988 | 0.5500 | MN20160304_L02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 32.28 | 770.25 | 2382 | 3392 | 0.7021 | 0.6952 | MN20160304_L02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 32.28 | 770.25 | 2018 | 3392 | 0.5948 | 0.5687 | MN20160304_L02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 34.50 | 770.25 | 2540 | 3712 | 0.6843 | 0.6920 | MN20160304_L02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 34.50 | 770.25 | 2135 | 3712 | 0.5752 | 0.5673 | MN20160304_L02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 36.73 | 770.25 | 2683 | 4086 | 0.6566 | 0.6794 | MN20160304_L02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 36.73 | 770.25 | 2249 | 4086 | 0.5504 | 0.5607 | MN20160304_L02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 38.95 | 770.25 | 2784 | 4543 | 0.6127 | 0.6517 | MN20160304_L02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 38.95 | 770.25 | 2411 | 4543 | 0.5306 | 0.5615 | MN20160304_L02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 41.17 | 770.25 | 2978 | 5010 | 0.5943 | 0.6496 | MN20160304_L02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 41.17 | 770.25 | 2561 | 5010 | 0.5111 | 0.5601 | MN20160304_L02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 43.39 | 770.25 | 3104 | 5404 | 0.5744 | 0.6419 | MN20160304_L02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 43.39 | 770.25 | 2667 | 5404 | 0.4935 | 0.5556 | MN20160304_L02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 45.61 | 770.25 | 3271 | 5813 | 0.5627 | 0.6421 | MN20160304_L02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 45.61 | 770.25 | 2813 | 5813 | 0.4839 | 0.5593 | MN20160304_L02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 47.83 | 770.25 | 3408 | 6223 | 0.5476 | 0.6378 | MN20160304_L02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 47.83 | 770.25 | 2976 | 6223 | 0.4782 | 0.5658 | MN20160304_L02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 50.05 | 770.25 | 3620 | 6629 | 0.5460 | 0.6459 | MN20160304_L02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 50.05 | 770.25 | 3115 | 6629 | 0.4699 | 0.5682 | MN20160304_L02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 52.27 | 770.25 | 3841 | 7058 | 0.5441 | 0.6532 | MN20160304_L02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 52.27 | 770.25 | 3316 | 7058 | 0.4698 | 0.5789 | MN20160304_L02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 54.49 | 770.25 | 4014 | 7555 | 0.5313 | 0.6506 | MN20160304_L02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 54.49 | 770.25 | 3480 | 7555 | 0.4606 | 0.5806 | MN20160304_L02 | F04 |